|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 395.80 SEK | +2.27% |
|
+17.45% | +18.93% |
| 02-06 | Danske Bank Raises Price Target for Sobi to 430 Kronor (388), Reiterates Buy - BN | FW |
| 02-06 | DNB Carnegie Raises Target Price for Sobi to 450 Kronor (400), Reiterates Buy | FW |
| Capitalization | 137B 15.19B 12.84B 11.77B 11.14B 20.76B 1,375B 21.63B 54.1B 661B 56.95B 55.77B 2,405B | P/E ratio 2025 |
243x | P/E ratio 2026 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise value | 147B 16.37B 13.84B 12.68B 12.01B 22.38B 1,482B 23.31B 58.32B 713B 61.39B 60.13B 2,593B | EV / Sales 2025 |
4.06x | EV / Sales 2026 * | 4.59x |
| Free-Float |
51.66% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Swedish Orphan Biovitrum AB
| 1 day | +2.27% | ||
| 1 week | +17.45% | ||
| Current month | +17.45% | ||
| 1 month | +17.24% | ||
| 3 months | +21.41% | ||
| 6 months | +44.45% | ||
| Current year | +18.93% |
| 1 week | 335.6 | 395.8 | |
| 1 month | 322 | 395.8 | |
| Current year | 322 | 395.8 | |
| 1 year | 241.8 | 395.8 | |
| 3 years | 197.9 | 395.8 | |
| 5 years | 127.1 | 395.8 | |
| 10 years | 89.5 | 395.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 61 | 22/05/2017 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 59 | 20/07/2018 |
| Chief Tech/Sci/R&D Officer | 55 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Staffan Schüberg
BRD | Director/Board Member | 57 | 01/01/2020 |
| Director/Board Member | 70 | 01/01/2021 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.27% | +17.45% | +23.30% | +67.93% | 15.17B | ||
| +2.46% | +5.94% | +10.64% | +2.02% | 80.61B | ||
| -0.41% | -0.51% | -33.11% | -41.41% | 61B | ||
| -2.31% | +2.58% | +38.44% | +244.10% | 58.81B | ||
| -1.88% | +66.80% | +66.80% | +66.80% | 52.77B | ||
| +8.53% | +11.84% | +42.33% | -30.97% | 29.52B | ||
| +5.48% | +8.31% | +46.22% | +33.88% | 21.28B | ||
| -0.50% | -1.97% | +119.31% | +84.45% | 17.65B | ||
| +0.34% | -6.94% | +25.80% | -76.03% | 16.02B | ||
| -0.04% | -.--% | +3.83% | +178.97% | 14.02B | ||
| Average | +1.39% | +2.75% | +34.35% | +52.98% | 36.69B | |
| Weighted average by Cap. | +0.92% | +2.65% | +26.67% | +52.16% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 28.43B 3.16B 2.67B 2.44B 2.32B 4.31B 286B 4.49B 11.24B 137B 11.83B 11.59B 500B | 31.33B 3.48B 2.94B 2.69B 2.55B 4.75B 315B 4.95B 12.39B 151B 13.04B 12.77B 551B |
| Net income | 633M 70.23M 59.37M 54.42M 51.53M 96M 6.36B 100M 250M 3.06B 263M 258M 11.12B | 5.83B 647M 547M 502M 475M 885M 58.61B 922M 2.31B 28.17B 2.43B 2.38B 102B |
| Net Debt | 10.68B 1.19B 1B 918M 870M 1.62B 107B 1.69B 4.22B 51.6B 4.45B 4.35B 188B | 7.1B 788M 666M 610M 578M 1.08B 71.34B 1.12B 2.81B 34.29B 2.95B 2.89B 125B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/02/26 | 395.80 kr | +2.27% | 701,230 |
| 05/02/26 | 387.00 kr | +7.98% | 1,235,238 |
| 04/02/26 | 358.40 kr | +0.45% | 465,195 |
| 03/02/26 | 356.80 kr | +3.24% | 505,076 |
| 02/02/26 | 345.60 kr | +2.55% | 220,049 |
Delayed Quote Nasdaq Stockholm, February 06, 2026 at 08:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















